BMI on Trial—Should It Still Define Obesity

Explore this recorded session focusing on obesity from the American Diabetes Association’s Scientific Sessions. This on-demand video highlights emerging research, evolving clinical guidance, therapeutic advances, and new perspectives on the physiology, assessment, and management of obesity.

Overview

Learning Objectives

Identify the strengths and limitations of BMI when assessing adiposity and obesity-related health risk.
Distinguish clinical obesity from preclinical obesity using the diagnostic framework proposed by the Lancet Commission on Clinical Obesity.
Select an appropriate approach to confirming excess adiposity and evaluating obesity-related organ or functional impairment.
Identify how different obesity definitions may affect risk stratification, treatment goals, resource allocation, and access to care.

Faculty

Leigh Perrault, MD, DABOM

Franceso Rubino, MD

Summary

Availability:

On-Demand

Expires on Jan 01, 2028

Cost:

FREE

Credit Offered:

No Credit Offered

Create Account